- Home
- BOTJ vs CNTB Comparison
BOTJ vs CNTB Comparison
Compare BOTJ & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BOTJ | CNTB |
|---|---|---|
| Founded | 1998 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 135.1M | 140.4M |
| IPO Year | 2015 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BOTJ | CNTB |
|---|---|---|
| Price | $25.90 | $0.69 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 36.1K | ★ 847.7K |
| Earning Date | 10-30-2026 | 11-24-2026 |
| Dividend Yield | ★ 2.42% | N/A |
| EPS Growth | ★ 13.71 | N/A |
| EPS | ★ 1.32 | N/A |
| Revenue | ★ $4,273,000.00 | $64,000.00 |
| Revenue This Year | N/A | $11,287.85 |
| Revenue Next Year | N/A | $74.11 |
| P/E Ratio | $18.77 | ★ N/A |
| Revenue Growth | ★ 6.74 | N/A |
| 52 Week Low | $16.49 | $0.71 |
| 52 Week High | $30.84 | $3.82 |
Technical Indicators
Market Signals| Indicator | BOTJ | CNTB |
|---|---|---|
| Relative Strength Index (RSI) | 48.79 | 34.25 |
| Support Level | $22.99 | N/A |
| Resistance Level | $26.84 | $2.62 |
| Average True Range (ATR) | 1.32 | 0.07 |
| MACD | -0.17 | 0.02 |
| Stochastic Oscillator | 36.58 | 5.14 |
Price Performance
Historical ComparisonAbout BOTJ Bank of the James Financial Group Inc.
Bank of the James Financial Group Inc is a bank holding company that provides retail and commercial banking, deposit services, lending services, mortgage brokerage services, and other banking services. The company provides a range of deposit services including checking accounts, savings accounts and other time deposits of various types, ranging from daily money market accounts to longer-term certificates of deposit. It offers various types of secured and unsecured consumer loans, including personal loans, lines of credit, overdraft lines of credit, automobile loans, installment loans, demand loans, and home equity loans. It operates three business segments community banking; mortgage banking, and investment advisory services.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.